ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 142 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q4 2021. The put-call ratio across all filers is 0.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $6,000 | – | 170 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACT CAPITAL MANAGEMENT, LLC | 253,300 | $6,829,000 | 7.22% |
| Integral Health Asset Management, LLC | 125,000 | $3,370,000 | 0.88% |
| Green Alpha Advisors, LLC | 23,013 | $620,000 | 0.42% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 24,915 | $672,000 | 0.41% |
| Nikko Asset Management Americas, Inc. | 1,402,078 | $37,856,000 | 0.28% |
| ARK Investment Management | 2,383,840 | $64,268,000 | 0.27% |
| FEDERATED HERMES, INC. | 3,761,900 | $101,421,000 | 0.23% |
| PDT Partners, LLC | 49,500 | $1,335,000 | 0.12% |
| NinePointTwo Capital LLC | 12,417 | $334,000 | 0.09% |
| Hennion & Walsh Asset Management, Inc. | 59,385 | $1,601,000 | 0.08% |